In summary, pancreatic cancer immunotherapy is gradually shifting from clinical feasibility validation to research on microenvironment modulation, mechanisms of treatment drug resistance, and tumor progression driven by immune-inflammatory processes, demonstrating a clear trend toward in-depth development.
← all excerpts
Bibliometric analysis of global research trends in pancreatic cancer immunotherapy.
1
—
—